Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on May 14, 2025
Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements
GlobeNewswire
·
May 14, 2025
SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of …
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
GlobeNewswire
·
May 14, 2025
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in …
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
May 14, 2025
BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 14, 2025
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 14, 2025
Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for sNDA submission in Q3 2025; designed to reduce treatment …
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
GlobeNewswire
·
May 14, 2025
Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext …
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
GlobeNewswire
·
May 14, 2025
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
·
May 14, 2025
VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 14, 2025
On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human …
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the PIK3CA mutant cohort of the VIKTORIA-1 …
Physician Reveals Concerning Trend in Health Care Pricing and What Can Be Done About It
EIN Presswire
·
May 14, 2025
TX, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- Surveys show most doctors are increasingly concerned about a trend in health care pricing; patients being charged more for the same service, depending on where they go. And most don’t even know it’s …
Fluoroscopy Market Set for Growth Driven by Rising Chronic Diseases, Aging Population, and Demand
EIN Presswire
·
May 14, 2025
Increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and advancements in fluoroscopy technologies. VANCOUVER, BRITISH COLUMBIA, CANADA, May 14, 2025 /EINPresswire.com/ -- The Fluoroscopy Market is expected to grow …
Global Deeptech Conference at OIST in Okinawa, Japan Opens Startup Pitch Applications for Entrepreneurs
EIN Presswire
·
May 14, 2025
Unlocking Japan’s Deep Tech Startup Frontier—Apply Now to Pitch Your Startup on a Global Stage ONNA VILLAGE, OKINAWA, JAPAN, May 14, 2025 /EINPresswire.com/ -- Lifetime Ventures proudly announces OIST-Lifetime Startup Elevate 2025 (Startup Elevate 2025 …
Lyme Disease Testing Market Growth Research Report 2024-2033 | 250 Pages
EIN Presswire
·
May 14, 2025
The global Lyme Disease Testing market size is expected to grow from USD 11.5 bn by the end of 2024 to USD 24.6 bn by 2033, registering a revenue CAGR of 8.80% VANCOUVER, BC, CANADA, May 14, 2025 /EINPresswire.com/ -- The global Lyme Disease Testing …
Arcturis and University College London Hospitals Enter Strategic Partnership
EIN Presswire
·
May 14, 2025
Multi-year agreement to focus on generation of regulatory grade real-world datasets to advance development and adoption of new medicines OXFORD, UNITED KINGDOM, May 14, 2025 /EINPresswire.com/ -- Arcturis, the UK leader in the curation of deep, multi- …
US FDA Orphan Drug Rare Disease Market Clinical Trials Drug Sales Insight 2030
GlobeNewswire
·
May 14, 2025
Delhi, May 14, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …
Sky Zone Appoints David Hoffmann as its New Chief Executive Officer
GlobeNewswire
·
May 14, 2025
PROVO, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Sky Zone, the leader in the indoor active-entertainment industry, today announced that David Hoffmann has been named its new Chief Executive Officer, effective June 2, 2025. Mr. Hoffmann succeeds Shawn Hassel, …
United Way of Hunterdon County Offers Free Youth Mental Health Training to Address Escalating Youth Mental Health Crisis
EIN Presswire
·
May 14, 2025
Learn how to support teens in crisis—free Youth Mental Health First Aid training for parents, coaches, and volunteers who care about youth well-being. FLEMINGTON, NJ, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- United Way of Hunterdon County is …
Virtual Companion Care Market Set to Surpass USD 14.4 Million by 2033, witness a CAGR of 6.2% | FMI
EIN Presswire
·
May 14, 2025
Explore key trends, drivers, and forecasts shaping the Virtual Companion Care Market from 2023 to 2033 NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The virtual companion care market is expected to secure a CAGR of 6.2% during the …
Global Veterinary Orthotics-Prosthetics Market Set to Surge Past USD 140.0 Million by 2035, grow at a CAGR of 6.4% | FMI
EIN Presswire
·
May 14, 2025
Global Veterinary Orthotics and Prosthetics Market to Witness Robust Growth Driven by Advancements in Animal Mobility Solutions (2025–2035) NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The global veterinary orthotics-prosthetics market …